ISRCTN86839890已完成不适用
A pilot study to assess the safety and efficacy of the Transcend CyPass glaucoma implant in combination with cataract surgery in patients with open angle glaucoma
Transcend Medical, Inc.™ (USA)0 个研究点目标入组 20 人开始时间: 2010年6月17日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Patients must be age 18 or over, either sex
- •2. Patients must have diagnosis of primary open angle glaucoma or ocular hypertension (OHT). Also acceptable are patients diagnosed with open angle glaucoma associated with pseudoexfoliation syndrome or pigmentary glaucoma.
- •3. Candidacy for cataract surgery in the study eye as determined by the clinical judgment of the investigator
- •4. Patients who have had previous trabeculoplasty glaucoma procedures such as argon laser trabeculoplasty (ALT) or selective laser trabeculoplasty (SLT)
- •5. Patients must have intraocular pressure (IOP) of greater than or equal to 21 mmHg and less than or equal to 40 mmHg while on maximal tolerated medical therapy, documented at two sequential visits at any time of day, at least 48 hours apart, within 30 days prior to surgery
- •6. Patients must have sufficient space in the angle to accommodate the device
- •7. Patients must be able to understand the requirements of the study and be willing to follow study instructions, to provide written informed consent to participate, and who agree to comply with all study requirements, including the required study follow-up visits
排除标准
- •1. Patients with previous glaucoma surgery, including trabeculectomy or implantation of any aqueous shunt device, or the following glaucoma surgeries: viscocanulostomy, cyclophotocoagulation, or collagen implant
- •2. Patients with any ophthalmic surgery within 3 months in the eye to be treated
- •3. Patients with diagnosis of angle closure following penetrating keratoplasty, neovascular glaucoma, congenital glaucoma, developmental glaucoma or previous goniotomy
- •4. Patients with active uveitis within six months or other secondary glaucomas (other than pseudoexfoliation syndrome or pigmentary glaucoma)
- •5. Patients with best corrected visual acuity less than 20/200 in the fellow eye
- •6. Patients with clinically significant inflammation or infection within 6 months prior to the study
- •7. Patients with active diabetic retinopathy
- •8. Patients who have any uncontrolled systemic disease (e.g., diabetes, hypertension, etc.) in the opinion of the investigator
- •9. Intolerance or hypersensitivity to topical anesthetics, mydriatics, or components of the device
- •10. A medical condition, serious illness, or extenuating circumstance that would significantly decrease study compliance, including all prescribed follow-up
- •11. Any condition that, in the opinion of the investigator, would jeopardize the safety of the patient
- •12. Participation in any study involving an investigational drug within the past 30 calendar days, or ongoing participation in a study with an investigational device
- •13. Patients who are pregnant or planning to be pregnant during the course of the study
研究者
相似试验
已完成
不适用
Safety and efficacy of Transcend CyPass glaucoma implant in open angle glaucoma patients who have failed medical treatmentPrimary open angle glaucomaEye DiseasesGlaucomaISRCTN23263504Transcend Medical, Inc.™ (USA)20
进行中（未招募）
不适用
A pilot study to assess the efficacy and safety of LCQ908 alone and in combination with fenofibrate or Lovaza® in patients with severe hypertriglyceridemiaon Familial Chylomicronemia Syndrome (Non-FCS)MedDRA version: 14.1Level: LLTClassification code 10020870Term: HypertriglyceridemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersNon Familial Chylomicronemia Syndrome (Non-FCS)EUCTR2012-000872-40-CZovartis Pharma Services AG60
已完成
3 期
A pilot study to assess the efficacy and safety of Heliox inhalation therapy for resuscitation to preterm infants.preterm infantsJPRN-UMIN000015061agano Children's Hospital10
进行中（未招募）
1 期
A preliminary study to assess if low dose iron is safe and effective in patients with inflammatory bowel diseaseIron deficiency anaemia in inflammatory bowel diseaseMedDRA version: 20.0Level: LLTClassification code 10002062Term: Anaemia iron deficiencySystem Organ Class: 100000004851MedDRA version: 20.1Level: PTClassification code 10021972Term: Inflammatory bowel diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersEUCTR2018-002982-20-GBRoyal Liverpool University Hospital30
已完成
不适用
Pilot Study Evaluating the efficacy and safety of Polymyxin B-immobilized Fiber Column (PMX) Hemoperfusion Treatment for Idiopathic Pulmonary Fibrosis with Acute ExacerbatioIdiopathic pulmonary fibrosisJPRN-UMIN000013116ippon Medical School Hospital20